This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Labiós, M. Articles by Muñoz, A. Search for Related Content PubMed PubMed Citation Articles by Labiós, M. Articles by Muñoz, A. Social Bookmarking                         What's this?

Superoxide dismutase and catalase anti-oxidant activity in leucocyte lysates from hypertensive patients: effects of eprosartan treatment

Internal Medicine Service, Clinic University Hospital, Valencia, Spain

Marcial Martínez

Clinical Pathobiology Service, La Fe University Hospital, Valencia, Spain, martinez_mar@ gva.es

Francisco Gabriel

Internal Medicine Service, Clinic University Hospital, Valencia, Spain

Victoria Guiral

Internal Medicine Service, Clinic University Hospital, Valencia, Spain

Francisco Dasi

Research Foundation, Clinic University Hospital, Valencia, Spain

Belén Beltrán

Clinical Pathobiology Service, La Fe University Hospital, Valencia, Spain

Anna Muñoz

Solvay Pharmaceuticals, Barcelona, Spain

Introduction. In an earlier study, our group reported that circulating leucocytes in hypertensive (HT) patients show a significant increase in oxidative stress compared to the control group, and this normalised after two months of treatment with eprosartan.¹ It can be speculated that these facts may be attributable to a possible reduction in anti-oxidative activity in untreated HT patients, which would be corrected by eprosartan.

Materials and methods. In this observational pilot study, superoxide dismutase and catalase activities were evaluated in leucocyte lysates in a group of 21 HT patients at baseline and after two months of treatment with eprosartan (600 mg/ day). For the control group, 25 normotensive volunteers were recruited with comparable characteristics to the patients.

Results. The results obtained indicate, paradoxically, that the untreated HT patients present greater anti-oxidant enzyme activity than the control group.

Conclusion. This result could be interpreted as a cell defence mechanism against the greater oxidative stress that exists in these patients.This hypothesis is consistent with the facts reported previously by our group in which a reduction in oxidative stress was found after two months of treatment with eprosartan. ¹ Upon reducing this stress, less anti-oxidative activity would be necessary, just as was observed in the present study after two months of treatment with eprosartan.

Key Words: catalase activity • eprosartan • hypertension • superoxide dismutase

References

• Labiós M., Martínez M., Gabriel F. et al. Effects of eprosartan on mitochondrial membrane potential and hydrogen peroxide production in leucocytes in hypertension. J Human Hypertens 2008;22:493-500.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kumar KV, Das UN Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993;19:59-66.[Web of Science][Medline] [Order article via Infotrieve]
• Beyer W., Imlay J., Fridovich I. Superoxide dismutases. Prog Nucleic Acid Res Mol Biol 1991;40:221-53.[Web of Science][Medline] [Order article via Infotrieve]
• Crapo JD, Oury C., Rabouille C., Slot JW, Chang LY Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc Natl Acad Sci U S A 1992;89:10405-09.[Abstract/Free Full Text]
• Stallings W. et al. The three-dimensional structure of iron superoxide dismutase: kinetics and structural comparisons with Cu/Zn and Mn dismutases. In: Oxygen Radicals in Chemistry and Biology. Berlin: Walter de Gruyter & Co., 1984;779-92.
• Mueller S., Weber A., Fritz R. et al. Sensitive and real-time determination of H2O2 release from intact peroxisomes. Biochem J 2002;363:483-91.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Goth L., Rass P., Pay A. Catalase enzyme mutations and their association with diseases. Mol Diagn 2004;8:141-9.[CrossRef][Medline] [Order article via Infotrieve]
• El Bekay R., Alvarez M., Monteseirin J. et al. Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NK-&B. Blood 2003;102:662-71.[Abstract/Free Full Text]
• Bradford MM A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Nebot C., Moutet H., Huet P., Xu JZ, Yadan JC, Chaudiere J. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 1993;214:442-51.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kidson CH Variations in catalase activity in human leucocytes. Blood 1962;19:82-8.[Abstract/Free Full Text]
• Boyajian RA, Otis SM Atherogenic progression of carotid stenosis associates selectively with monocyte fraction in circulating leucocytes. Eur J Neurol 2002;9:307-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mills PJ, Farag NH, Perez C., Dimsdale JE Peripheral blood mononuclear cell CD62L and CD11a expression and soluble interstitial cell adhesion molecule-1 levels following infused isoproterenol in hypertension. J Hypertens 2002; 20:311-16.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Held C., Hjemdahl P., Hakan Wallen N. et al. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APIS study. The angina prognosis study in Stockholm. Atherosclerosis 2000;148:179-88.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ruilope L., Jäger B., Prichard B. Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial. Blood Press 2001;10:223-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hedner T. The clinical profile of the angiotensin II receptor blocker eprosartan. J Hypertens 2002;20(suppl 5): S33-8.
• Conter HS, McKay DW, Reiz RJ Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting. Can J Cardiol 2004;20(suppl C): 6C-10C.[Web of Science][Medline] [Order article via Infotrieve]
• Romero JC, Reckelhoff JF Role of angiotensin and oxidative stress in arterial hypertension. Hypertension 1999;34:943-9.[Abstract/Free Full Text]
• Wilcox CS Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 2002;4:160-6.[Web of Science][Medline] [Order article via Infotrieve]
• Vaziri ND, Liang K., Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 1999;56:1492-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Vaziri ND, Ni Z., Oveisi F., Trnavsky-Hobbs DL Effect of antioxidant therapy on blood pressure, and NO synthase expression in hypertensive rats. Hypertension 2000;36:957-64.[Abstract/Free Full Text]
• Makino A., Skelton MM, Zou AP, Roman RJ, Cowley AW Increased renal medullary stress produces hypertension. Hypertension 2002;39:667-72.[Abstract/Free Full Text]
• Touyz RM Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther 2003;1:91-106.[CrossRef][Medline] [Order article via Infotrieve]
• Yasunari K., Maeda K., Nakamura M., Yoshikawa J. Oxidative stress in leucocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 2002;39:377-80.
• Yasunari K., Maeda K., Nakamura M., Yoshikawa J. Pressure promotes angiotensin II-mediated migration of human coronary smooth muscle cells through increase in oxidative stress. Hypertension 2002;39:433-7.[Abstract/Free Full Text]
• Labiós M., Martínez M., Gabriel F., Guiral V., Muñoz A., Aznar J. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension. Am J Hypertens 2004;17:757-63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Yasunari K., Maeda K., Nakamura M., Watanabe T., Yoshikawa J., Asada A. Effect of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension. Am J Med 2005;118:201-02.[Web of Science][Medline] [Order article via Infotrieve]
• Yasunari K., Maeda K., Nakamura M., Watanabe T., Yoshikawa J. Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension. Hypertens Res 2005;28:107-12.[CrossRef][Medline] [Order article via Infotrieve]
• Khassaf M., McArdle A., Esanu C. et al. Effect of vitamin C supplements on antioxidant defence and stress proteins in human lymphocytes and skeletal muscle. J Physiol 2003; 549:645-52.[Abstract/Free Full Text]
• Wilcox CS, Welch WJ Oxidative stress: cause or consequence of hypertension. Exp Biol Med 2001;226:619-20.[Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 10, No. 1, 24-30 (2009)
DOI: 10.1177/1470320309104067


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Labiós, M. Articles by Muñoz, A. Search for Related Content PubMed PubMed Citation Articles by Labiós, M. Articles by Muñoz, A. Social Bookmarking                         What's this?